Organoclick AB (ORGC) — Cash Flow-to-Debt Ratio
Organoclick AB (ORGC) has a Cash Flow-to-Debt Ratio of 0.03x as of December 2025, meaning its operating cash flow of Skr2.97 Million could theoretically repay 0% of its total liabilities (Skr114.81 Million) in one year. See ORGC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Organoclick AB Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Organoclick AB across 14 annual periods. Also explore how fast is Organoclick AB growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Organoclick AB (2012–2025)
Year-by-year debt coverage analysis for Organoclick AB. For market capitalisation and broader financial context, see market value of Organoclick AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | Skr-8.29 Million | Skr114.81 Million | ▼ -278.7% |
| 2024 | 0.04x | Skr3.60 Million | Skr89.15 Million | ▲ +637.9% |
| 2023 | 0.01x | Skr533.00K | Skr97.34 Million | ▲ +102.5% |
| 2022 | -0.22x | Skr-21.22 Million | Skr95.30 Million | ▲ +52.3% |
| 2021 | -0.47x | Skr-37.69 Million | Skr80.66 Million | ▼ -696.6% |
| 2020 | 0.08x | Skr5.47 Million | Skr69.86 Million | ▲ +150.3% |
| 2019 | -0.16x | Skr-11.01 Million | Skr70.73 Million | ▲ +56.7% |
| 2018 | -0.36x | Skr-19.16 Million | Skr53.30 Million | ▲ +17.6% |
| 2017 | -0.44x | Skr-20.72 Million | Skr47.49 Million | ▼ -18.7% |
| 2016 | -0.37x | Skr-15.55 Million | Skr42.31 Million | ▲ +65.6% |
| 2015 | -1.07x | Skr-24.42 Million | Skr22.83 Million | ▼ -11.2% |
| 2014 | -0.96x | Skr-17.28 Million | Skr17.96 Million | ▼ -2767.1% |
| 2013 | 0.04x | Skr313.54K | Skr8.69 Million | ▲ +101.4% |
| 2012 | -2.67x | Skr-18.47 Million | Skr6.92 Million | — |